Skip to content

URMC Response to CrowdStrike Software Issue

Saturday, July 20: All UR Medicine facilities are open as scheduled and providing safe patient care, with a goal to return all clinical services to full efficiency by early next week.

Patients: click here for more information. Faculty/Staff: click here for information.

Home
Michael Ashenafi, M.S.

Michael Ashenafi, M.S.

About Me

Michael Ashenafi is a Medical Physicist in the Department of Radiation Oncology at the University of Rochester Medical Center. He graduated Summa Cum Laude from Southern University in 2002. He received his MS degree in Medical and Health Physics from Louisiana State University in 2006. Prior to join...
Michael Ashenafi is a Medical Physicist in the Department of Radiation Oncology at the University of Rochester Medical Center. He graduated Summa Cum Laude from Southern University in 2002. He received his MS degree in Medical and Health Physics from Louisiana State University in 2006. Prior to joining University of Rochester, he worked as Assistant Professor at Medical University of South Carolina for 12 years.

His research interests include:
• Practical clinical workflow for image-guided HDR Brachytherapy
• Image guided teletherapy and brachytherapy

Faculty Appointments

Associate - Department of Radiation Oncology (SMD)

Credentials

Education

MS | Louisiana State University. Medical and Health Physics. 2006

BS | Southern University. Physics. 2002

Awards

Recipient of Integrating Radiobiology with Medical Physics (IBPRO) scholarship. 2017 - 2017

Young Investigator (1st place). 2006 - 2006

National Society of Collegiate Scholars (NSCS). 2005

Grand Marshall. 2002

Publications

Journal Articles

A quick guide on implementing and quality assuring 3D printing in radiation oncology

Ashenafi M; Jeong S; Wancura JN; Gou L; Webster MJ; Zheng D.

J Appl Clin Med Phys. 2023; 24(11): e14102.

Iris melanoma presenting as childhood glaucoma.

Gapsis BC, Warren NA, Nutaitis MJ, Bonaparte LA, Cooper SL, Ashenafi M, Grossniklaus HE, Magrath GN

American journal of ophthalmology case reports.. 2018 September 11 :56-60. Epub 05/26/2018.

Pretreatment albumin may aid in patient selection for intrahepatic Y-90 microsphere transarterial radioembolization (TARE) for malignancies of the liver.

Orwat KP, Beckham TH, Cooper SL, Ashenafi MS, Anderson MB, Guimaraes M, Yamada R, Marshall DT

Journal of gastrointestinal oncology.. 2017 December 8 (6):1072-1078. Epub 1900 01 01.

Validation of a modern second-check dosimetry system using a novel verification phantom.

McDonald DG, Jacqmin DJ, Mart CJ, Koch NC, Peng JL, Ashenafi MS, Fugal MA, Vanek KN

Journal of applied clinical medical physics. 2017 January 18 (1):170-177. Epub 1900 01 01.

Implementation and Advantages of a Pre-Planning Technique for Interstitial Gynecological Brachytherapy

Michael Ashenafi, Chris Mart, Jean Peng, Lewis Cooper, Kenneth Vanek.

Brachytherapy. 2017; 16(3): S72 - S73.

Target Based Prescription for Intracavitary Brachytherapy in Cancer of the Cervix. Medical Physics

M Ashenafi, D McDonald, J Peng, C Mart, N Koch, L Cooper, K Vanek:.

Medical Physics. 2016; 43(6): 3469-3469.

A Comparative Case Study Among Four Modalities for the Superficial Treatment of Squamous Cell Carcinoma

M Ashenafi, N Koch, J Peng, L Terwillinger, J Wilder, D McDonald, C Mart, J Jenrette, K Vanek.

Medical Physics. 2016; 43(6): 3467-3467.

Assessment of a three-dimensional (3D) water scanning system for beam commissioning and measurements on a helical tomotherapy unit.

Peng JL, Ashenafi MS, McDonald DG, Vanek KN

Journal of applied clinical medical physics. 2015 January 816 (1):4980. Epub 01/08/2015.

Slug expression inhibits calcitriol-mediated sensitivity to radiation in colorectal cancer.

Findlay VJ, Moretz RE, Wang C, Vaena SG, Bandurraga SG, Ashenafi M, Marshall DT, Watson DK, Camp ER

Molecular carcinogenesis.. 2014 February 53 Suppl 1 (0 1):E130-9. Epub 08/31/2013.

Comparison of radiation treatment delivery for pancreatic cancer: Linac intensity-modulated radiotherapy versus helical tomotherapy.

Taylor R, Opfermann K, Jones BD, Terwilliger LE, McDonald DG, Ashenafi MS, Garrett-Meyer E, Marshall DT

Journal of medical imaging and radiation oncology.. 2012 June 56 (3):332-7. Epub 04/11/2012.

Comparison of intraoperatively built custom linked seeds versus loose seed gun applicator technique using real-time intraoperative planning for permanent prostate brachytherapy.

Zauls AJ, Ashenafi MS, Onicescu G, Clarke HS, Marshall DT

International journal of radiation oncology, biology, physics.. 2011 November 1581 (4):1010-6. Epub 10/01/2010.

Calibration of the Gamma Knife Perfexion using TG-21 and the solid water Leksell dosimetry phantom.

McDonald D, Yount C, Koch N, Ashenafi M, Peng J, Vanek K

Medical physics.. 2011 March 38 (3):1685-93. Epub 1900 01 01.

Feasibility of postmastectomy treatment with helical TomoTherapy.

Ashenafi M, Boyd RA, Lee TK, Lo KK, Gibbons JP, Rosen II, Fontenot JD, Hogstrom KR

International journal of radiation oncology, biology, physics.. 2010 July 177 (3):836-42. Epub 10/30/2009.

Imaging applications in multicatheter brachytherapy for soft tissue sarcomas.

Harper JL, Watkins JM, Ashenafi M, Li J

Cancer imaging : the official publication of the International Cancer Imaging Society.. 2010 June 1710 (1):127-34. Epub 06/17/2010.

Helical tomotherapy for total lymphoid irradiation.

McCutchen KW, Watkins JM, Eberts P, Terwilliger LE, Ashenafi MS, Jenrette JM

Radiation medicine.. 2008 December 26 (10):622-6. Epub 01/08/2009.

Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy.

Watkins JM, Harper JL, Dragun AE, Ashenafi MS, Sinha D, Li J, Cole DJ, Jenrette JM

Brachytherapy.. 2008 7 (4):305-9. Epub 09/07/2008.